Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100062133 | 10006213 | 3 | F | 2012 | 20140620 | 20140313 | 20140630 | EXP | US-PFIZER INC-2014070219 | PFIZER | 58.00 | YR | F | Y | 76.00000 | KG | 20140630 | N | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100062133 | 10006213 | 1 | PS | Lipitor | 1 | ORAL | 20 MG, DAILY | D | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
100062133 | 10006213 | 2 | SS | Lipitor | 1 | ORAL | 20 MG, DAILY | D | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
100062133 | 10006213 | 3 | SS | ATORVASTATIN CALCIUM | 1 | 20 MG, DAILY | D | 20702 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100062133 | 10006213 | 1 | Low density lipoprotein increased |
100062133 | 10006213 | 3 | Blood cholesterol abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100062133 | 10006213 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100062133 | 10006213 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100062133 | 10006213 | 1 | 200705 | 200904 | 0 | |
100062133 | 10006213 | 2 | 201203 | 201205 | 0 | |
100062133 | 10006213 | 3 | 201203 | 201306 | 0 |